All Chemistry World articles in May 2018
View all stories from this issue.
-
ReviewThe many lives of carbon
Dag Olav Hessen leaves no stone - or diamond - unturned in his account of element six
-
ReviewBuilt: the hidden stories behind our structures
The ‘storey’ of structural engineering, as told by Shard designer Roma Agrawal
-
PuzzleOn the spot: Expert reviewer
Should you review a paper that covers research you also work on?
-
ReviewSeeds of science: why we got it so wrong on GMOs
Katrina Kramer reviews the story of one man’s journey from activist to advocate
-
FeatureThe molecular basis of circadian rhythms
Every cell of every organism has its own little clock, but what makes it tick? Fiona Case finds out
-
OpinionDouma and Salisbury: a tale of two cities
Events in Salisbury and Douma show how important OPCW has become
-
OpinionThe clues that let you trace a single sheet of paper
Forensic science has a new way to detect document fraud
-
BusinessBig business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
-
-
-
-
OpinionWhat the pay gap report really means
The UK pay gap data is an important first step, not the last word
-
OpinionA sideways look at synthesis
Side products might not be what you want, but they could be what you need
-
OpinionJean-Pierre Sauvage: 'You'd be surprised about my taste in music!'
The molecular machine maven talks reading, Jagger and winning a Nobel prize
-
OpinionSuffering students: mental health in academia
We can all play a part in promoting good student mental health
-
ReviewScience not silence: voices from the March for Science movement
22 April 2017 remembered through a collection of photos and stories
-
Feature3D printing in pharma
Nina Notman explores how 3D printing is carving out a niche for itself in the pharmaceutical industry
-
-
OpinionWhy you should care about Fair data
The benefits of findable, accessible, interoperable and re-useable information
-
OpinionWhy combination pills aren’t always the answer
The challenges of medicines containing multiple drugs aren’t going away